Earlier today, Oakridge Global Energy Solutions, Inc. (OTCQB: OGES) announced an upcoming investors conference call, which is scheduled for Tuesday, March 22, 2016, at 2:00PM EST.

During the call, Steve Barber, the company’s executive chairman and chief executive officer, will expand upon Oakridge’s recent press announcements. In particular, Barber is expected to offer more details on the company’s recently unveiled strategic business alliance agreement with Tokyo-based trading house Sojitz Group, outlining what the new agreement means to both Oakridge and its shareholders. Other topics set to be discussed during the call include an update on revenue forecasts for the first quarter of 2016, the electric interstate truck project and the recent release of the Liberty Series motorcycle battery at the Daytona Beach Bikefest. Barber will also provide an update on the progress of shipments of Oakridge’s Pro Series golf car batteries.

The Call-In Number to access Tuesday’s conference call is +1 712-775-7035. The Access Code is 684304#.

“We started 2016 in full manufacturing mode and have continued to ramp up as the first quarter has progressed,” Barber stated in this morning’s news release. “We are currently shipping production product in the golf car and low speed electric vehicle markets; the radio controlled unmanned vehicles and drones markets; the motorcycle starter motor markets; and a number of very special custom applications. It is a very exciting time at Oakridge!”

Since the start of 2016, Oakridge has made tremendous progress toward expanding its foothold in the global stored energy market. Last month, the company powered a successful demonstration of Maritime Tactical Systems, Inc.’s Man-Portable Tactical Autonomous Systems (MANTAS) with a custom battery specially designed to function in a number of strenuous applications – including naval fleet protection, mine warfare, port and harbor security patrol, anti-piracy and search and rescue. Later in the same week, Oakridge announced plans to supply batteries to Freedom Trucking’s fully electric interstate truck propulsion system.

In early March, the company continued to build on its recent progress when it presented its state-of-the-art, ‘Made in the USA’ Pro-Series lithium ion golf car battery systems at the Orlando PGA Merchandise Show, one of the biggest annual golf industry conventions in the world. Oakridge followed up on this presentation with the commercial introduction of its lithium ion motorcycle batteries at the 75th annual Daytona Beach Bikefest, which concluded on March 14.

For more information, visit www.oakridgeglobalenergy.com

Let us hear your thoughts: Oakridge Global Energy Solutions, Inc. Message Board

In December 2015, the U.S. Department of Energy published the sixth edition of its annual report on the fuel cell industry. Issued by its Fuel Cell Technologies Office, the report is punned State of the States: Fuel Cells in America 2015. As expected, it is a wealth of information on the state of the industry, and it notes that Dominovas Energy Corporation (OTCQB: DNRG) is the only fuel cell company that has been named a Private Sector Partner (PSP) in a multi-stakeholder partnership sponsored by the United States government.

The report opens with a sunny prognosis: ‘The fuel cell industry – which surpassed $2.2 billion in annual sales in 2014 – continues to grow and is generating impressive benefits in a number of ways.’ An increasing number of states are supporting development of the industry because of the promise of additional jobs and increased tax revenues. Fuel cells offer many benefits. They ‘bolster the electric grid, provide reliable and resilient power, reduce emissions, reach remote and rural parts of the country, and utilize domestic sources of energy, including natural gas.’ Fuel cells are also gaining significance as a source of back-up power, particularly in keeping critical communication networks and data centers up and running, but also as a technology ‘to provide primary or backup power to ensure constant power through major storms, or other disruptive events’. From an industry perspective, fuel cells will boost exports and help America regain lost ground in manufacturing.

States are providing tax and other incentives for fuel cells. For example, the New York State Energy Research and Development Authority (NYSERDA) has provided financial incentives to support the installation and operation of continuous duty fuel cell systems in New York State, with up to $1 million available for fuel cell systems rated larger than 25kW. A fuel cell system that size will meet the energy needs of the typical household comfortably, and the federal government is lending its support as well. The IRS offers a Fuel Cell Motor Vehicle Credit ‘…if you purchase a fuel cell motor vehicle that is propelled by power that is derived from one or more cells that convert chemical energy directly into electricity. You must purchase the vehicle before January 1, 2017 and begin driving it in the year in which you claim the credit. The base credit is $4,000 for a fuel cell motor vehicle weighing up to 8,500 pounds and $10,000 – $40,000 for heavier vehicles.’ There is also the Business Energy Investment Tax Credit (ITC) under which a tax credit of 30 percent of the purchase price of a fuel cell system can be applied against income tax payable in the year that the unit is placed into service.

Many large businesses are seizing the fuel cell advantage. ‘Wal-Mart is the largest fuel cell customer for material handling equipment (MHE), deploying the technology to power more than 2,800 forklifts at warehouses in Ohio, Pennsylvania, New York, Illinois, Indiana and Minnesota, with more sites on the way. The company also uses stationary fuel cells to generate power for 44 Wal-Mart (NYSE: WMT) and Sam’s Club retail sites in California and Connecticut. Then there’s food service product distributor, Sysco (NYSE: SYY), which has expanded its fuel cell fleet to more than 800 fuel cell-powered forklifts operating at seven of its warehouses in California, Massachusetts, New York, Texas, Virginia, Pennsylvania, and Michigan. Over the last few years, AT&T (NYSE: T) has deployed fuel cells to provide primary power to almost two dozen data and call centers, as well as backup power to hundreds of cell phone towers in multiple states.’

Dominovas Energy Corporation is positioned to generate and sell electricity on a multi-megawatt scale by way of the commercial production of its Solid Oxide Fuel Cell (SOFC) technology, known as the RUBICON™. The RUBICON™, by design, will be a highly efficient, combustion-less, and virtually pollution free energy source that will provide electricity to power a wide array of systems, either through distributed power applications (in which power is generated by the user) or to the grid. The technology can be factored and scaled to provide power to entire cities. In principle, a fuel cell is an electrochemical device that operates like a battery. However, unlike a battery, a fuel cell does not require recharging, but refueling. The RUBICON™, as designed, will use fuel, principally hydrogen extracted from natural gas, propane, or other hydro-carbon based fuels along with oxygen extracted from air to produce electricity. The RUBICON™ system will produce energy in the form of electricity and heat as long as there is a constant fuel source. The RUBICON’s™ operation is also quite simple: it has minimal moving parts and operates quietly with low emissions.

For more information, visit www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

Over-the-counter (OTC) pain medications should be the first choice when trying to tolerate chronic pain. Ultra-addictive, narcotic pain medications produced by big pharma companies are so rampant in today’s world. Nutra Pharma Corp. (OTCQB: NPHC) is a biotech company working in collaboration with its subsidiaries to develop an innovative pipeline of biopharmaceutical products for the management of neurological disorders, cancer, autoimmune, and infectious diseases. At the core of Nutra Pharma’s intellectual property portfolio is a unique platform for extracting neurotoxins from Asian cobra venom and transforming them into non-toxic therapeutics.

Nutra Pharma’s product pipeline includes Nyloxin, an OTC pain reliever for humans, and Pet Pain-Away, a pain reliever for dogs and cats. The company’s Nyloxin product is the first OTC pain reliever clinically proven to treat moderate to severe chronic pain. The drug is available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

One problem with making a pain medication from cobra venom is the supply of cobra venom. Nutra Pharma has completed a series of projects to update and expand the facilities that house the Asian cobras utilized for the production of Nyloxin. Included with these updates was the addition of 100 snakes to the existing milking line to increase venom production in line with upcoming international orders from India and China.

“We are at an amazing inflection point for the Company,” Rik J. Deitsch, Chairman and CEO of Nutra Pharma, stated in a news release. “Over the past few months, we have dramatically reduced costs, paid down debt and recapitalized the share structure of the Company,” he continued. “Now we need to focus on increasing sales for our OTC products, Nyloxin and Pet Pain-Away. This also requires us to scale up our raw material supplies and production facilities. The growth-limiting material for Nutra Pharma is cobra venom, the active ingredient in our OTC products. We need to make sure that we have an adequate supply of validated material to meet our future production needs. With the recently announced expansion into India and China, we realize that we will need to grow exponentially to meet these expected product orders in the coming months. The expansion of the reptile facilities ensures that we can grow apace with the increasing orders.”

For more information on the company, visit www.NutraPharma.com

Let us hear your thoughts: Nutra Pharma Corp. Message Board

Dominovas Energy Corp. (OTCQB: DNRG) is resolute about its mission to electrify the world. Using a calculated approach backed by its technical prowess and access to project financing, Dominovas is moving forward with its plans to introduce and deploy technology that will transform the way electricity is delivered on the continent of Africa.

Using a complex set of solutions, Dominovas Energy addresses concerns about toxic carbon emissions, as well as reducing instances of equipment maintenance and inefficiencies. These are pervasive issues linked to power generation from diesel generators, combined-cycle gas-fired turbine power plants and other combustion-centric technologies. These are also major issues that result in increased costs.

After recognizing that alternative energy markets, like those in Africa, have massive potential for growth, Dominovas Energy began focusing its intellectual and financial capital on devising a green energy solution that is reliable, efficient and measurably cleaner than other alternatives. With its proprietary RUBICON™ Solid Oxide Fuel Cell (SOFC) technology, Dominovas Energy is preparing to deploy such a solution in multi-megawatt power generation units worldwide.

Countries and companies have entrusted Dominovas Energy to deliver its 21st century energy solutions and technology, having executed guaranteed multi-MW contracts in the Congo and having received a license to produce electricity in Angola. Last summer, the company publicized the execution of a guaranteed 200MW multi-year Power Provider Agreement (PPA) with the Democratic Republic of the Congo. As a result of the PPA, Dominovas Energy was tasked with providing electricity to the country’s South Kivu Province using its RUBICON™ Solid Oxide Fuel Cell system.

Late in the year, Dominovas Energy made strides in Angola, as well. The Angolan Ministry of Petroleum granted the company an independent Power Producer license that authorizes it to provide clean and reliable electricity to companies within the country’s oil and gas industry. Along with demonstrating the Angolan leadership’s dedication to new technologies, this marked a significant moment for Dominovas Energy: its RUBICON™ system became the first and only fuel cell-based technology solution to have been granted this license in Angola. This substantial accomplishment was also a capstone of the work the Dominovas Energy management team has done to push ahead the commercial proliferation of its SOFC fuel cell technology.

For more information, visit www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

With an already impressive portfolio of digital commerce technologies, Alternet Systems, Inc. (OTCQB: ALYI) plans to continue investing in more verticals within the industry. The company looks for innovative solutions to manage digital commerce, information, and payments. These solutions must improve efficiency and quicken the pace of commerce. Alternet also develops predictive data analytics applications for consumers and the telecommunications and financial industries, which are all high growth markets. Predictive analytics, itself a profitable marketing tool, is expected to grow exponentially over the next few years.

Predictive analytics and statistical analysis are based on observed actions in relation to future actions. Analysts choose a dependent variable based on something that has already occurred and compare that variable to other variables that could be related statistically through a predictive software. For example, companies can analyze traits of the customers who have already purchased their product and then see if these traits relate to other consumers. This information then allows companies to “microtarget” their desired audiences with effective marketing strategies. Using predictive analytics saves time and money, because companies only market to those individuals who share similar characteristics to the customers who have already purchased their products.

Alternet plans to offer software that integrates analytics, micro-segments, and automatic marketing technology. Clients will be able to view data across diverse sources about their unique audiences, which can help them develop micro-targeting tactics to push business forward. The software could even provide marketing recommendations.

Predictive analytics and micro-targeting aim to “reach the right people with the right message.” This segment has already gained momentum, with 2015 showing $242 million in funding for startups, as compared to $376 million for all previous years combined. The technology shows no signs of slowing down as the world continues to become more technologically dependent.

Going forward, Alternet stands to gain from these numbers with its strong digital commerce and predictive data analytics applications. The company intends to lead the digital commerce industry by continuously developing and harnessing innovative technology to keep up with the world’s growing demand.

For more information, visit www.alternetsystems.com

Let us hear your thoughts: Alternet Systems, Inc. Message Board

Before the opening bell, Halitron, Inc. (OTC: HAON) continued to build on what has been a hot start to 2016 through the finalization of its third acquisition of the year. ArchivalMuseumSupplies, a leading direct marketing brand from Plastic Retail Displays, LLC, is now part of the Halitron family of businesses. ArchivalMuseumSupplies targets an expansive customer base – including museums, libraries, archivists and professional photographers – by offering archival-grade storage products, such as metal edge storage boxes, envelopes, sleeves and bags, designed to help preserve valuable contents for an extended period of time.

“ArchivalMuseumSupplies competes in a niche market that has lower risks associated with economic downturns as the product is a staple within the niche archiving community,” Bernard Findley, chief executive officer of Halitron, stated in this morning’s news release. “The brand also opens up the opportunity to evaluate digital archiving based on leveraging the current customer base with new products and services.”

Halitron acquired the ArchivalMuseumSupplies brand for a total purchase price of $635,319, including $119,359 payable in a short term note and $515,960 paid via the issuance of restricted common stock. As part of this transaction, Halitron also acquired related equipment, molds and dies, raw material, finished goods, a customer list totaling more than 128,500 customers, the www.ArchivalMuseumSupplies.com website and a collection of digital artwork files.

ArchivalMuseumSupplies boasts an average order value (AOV) of $130.44, which will increase the company’s AOV by 8.6 percent to $116.98. After merging the ArchivalMuseumSupplies brand with its existing factory infrastructure, Halitron will look to add an additional 35 percent gross profit margin by manufacturing a number of products it sells to end users.

“Halitron, Inc. now owns NDG Holdings Inc., a digital marketing company (acquired Jan ’15), PRD Holdings Inc., a Mexican based factory (acquired Feb ’16), and two niche brands, PiecesInPlaces (acquired Feb ’16) and Archival Museum Supplies (acquired Mar ’16),” continued Findley. “The base business model is in full operations with strong digital marketing, efficient manufacturing, and well-known brands in niche markets.”

With the completion of its sixth acquisition since 2015, Halitron’s management team is actively seeking out additional acquisition candidates to roll into its existing infrastructure. Including its current pipeline of acquisitions, the company is currently on a run rate to generate over $10 million in sales over the next three years.

For more information, visit www.halitroninc.com

Let us hear your thoughts: Halitron, Inc. Message Board

People often cite the popular phrase, “You are what you eat.” It reminds us of the great extent to which diet affects long-term health. Even if we want to eat more wholesome foods, obtaining accurate information at the right time is not always easy. And what about the millions who suffer from food allergies and intolerances? In the U.S., there are about 15 million people who suffer from food allergies. 1 in 13 children are affected and continue to be at risk. A study released in 2013 by the Centers for Disease Control and Prevention (CDC) reported that food allergies among children increased approximately 50 percent between 1997 and 2011. For those who suffer, making the right choices could be a matter of life and death. Now, Content Checked Holdings, Inc. (OTCQB: CNCK) hosts a family of mobile apps that help sufferers of a variety of food allergies, dietary restrictions, or intolerances navigate the minefields of the modern food industry.

At present, Content Checked’s suite of apps includes ContentChecked, MigraineChecked and SugarChecked. ContentChecked, which was its first, is a smartphone application designed for use by those who suffer from food allergies and intolerances. The app allows its users to scan a product’s bar code and determine if it is suitable for the individual. MigraineChecked is a more specialized app that combines research on migraine triggers and their links to food ingredients. An estimated 38 million Americans suffer from migraine and chronic headaches. SugarChecked is another specialized app that identifies added sugars, artificial sweeteners, natural low-calorie sweeteners and sugar alcohols; the user can choose any or all of these four options.

The company’s family of apps provides easy shopping tools for consumers to decipher often-misleading food labels, and receive recommendations for healthier alternative products, by simply scanning the barcodes of grocery store products. Other features include an expansive recipe database with directions and ideas on food preparation for avoiding allergic reactions. Content Checked also maintains a database of allergens and food ingredients that indicates any relationship between the two. Currently, that database has information on more than 200,000 products available in the United States and is updated 24/7 by a team of nutritionists.

In a recent interview (http://dtn.fm/ju0GV) with ceolive.tv, CEO Kris Finstad pointed out the value of that database, which includes information on over 70 percent of food products available on the domestic market. Content Checked, through licensing agreements, has begun making this information available to third parties through cross-promotional partnerships.

Together ContentChecked, MigraineChecked and SugarChecked have had over 2 million downloads, and 66 percent of the apps’ users utilize the tools at least five times per week.

For more information, visit www.contentchecked.com

Let us hear your thoughts: ContentChecked Holdings Inc. Message Board

Star Mountain Resources, Inc. (OTC: SMRS), a minerals exploration company, pursues the acquisition and consolidation of mining claims, producing mines, mineral leases, and historic mines in the United States. The company explores for gold, silver, copper, lead, zinc, silica, and zircon deposits and holds interests in the Balmat Mine located in the Balmat mining district of St. Lawrence County, New York. SMRS also possesses an interest in the Star Mountain/Chopar project with 116 lode-mining claims and 4 metalliferous mineral leases, which cover 3,730 acres located in the Star mountain range of the Star mining district in Beaver County, Utah, and the Ogden Bay Minerals project located in West Ogden, Utah.

The company is steadfast with respect to the concern and focus it places in the area of environmental stewardship. SMRS knows its efforts in this area require precise planning and implementation to minimize impact and mitigate unavoidable changes to the environment. This planning is woven into the mine exploration stage early on and continues through construction, operation, and closure and reclamation.

Star Mountain Resources works tirelessly at ensuring that community involvement, environmental protection, environmental monitoring and employee and public safety are operational codes of conduct throughout every stage of the mining life cycle. Consideration of both current and potential environmental challenges are vital to the mining life cycle as the company works to minimize impact to the environment at its mine sites during ongoing improvement programs to meet federal, state, and local standards.

Star Mountain Resources places the safety and health of its dedicated workforce at the forefront of its thinking. It is the company’s policy to provide a safe and healthy workplace for every employee. This can only be achieved through intelligent action, cooperation, and an understanding of safe work practices. Safety is not reserved for compliance with rules and regulations. It is a mentality that extends to the development of personal work habits and practices that do not place the employees and their co‐workers at risk. Safety and production are integrated within each and every process, as no activity is viewed so important that it can justify engagement in unsafe acts or practices.

Star Mountain Resources, Inc. is a microcap mining company focused on the acquisition of mineral properties and their development into producing mines. SMRS is focused on a business climate it deems to be favorable for the low cost acquisition of high value mineral properties and intends to grow primarily through acquisitions. The company was formerly known as Jameson Stanford Resources Corporation before changing its name to Star Mountain Resources, Inc. in December 2014. Star Mountain Resources, Inc. is based in Tempe, Arizona.

For more information, visit www.starmountainresources.com

Let us hear your thoughts: Star Mountain Resources Inc. Message Board

We would like to correct the statement that iEntertainment Network acquired Tapster Interactive. According to the press release issued March 2, 2016, iEntertainment executed a Letter of Intent to acquire the game company. However, the acquisition hasn’t been finalized yet. The revised article can be found below.

iEntertainment Network, a developer of retail and online military simulation games, signed a letter of intent to acquire Tapster Interactive, Inc. (www.tapstargames.com). With this potential acquisition, Tapstar will become the publishing arm of iEntertainment Network. In related news, Tapstar has launched Kingdom Wars 2: Battles worldwide and has signed a publishing agreement with Shanghai-based developer T-Rex for its Immortal Legends mobile game. This release and signing are part of iEntertainment Network’s ongoing strategy of promoting financial growth through Tapstar’s publishing operations.

Kingdom Wars 2: Battles is a massive real-time strategy game with a fantasy theme. It has been released on the Steam Distribution Service, where it was recognized as a top five new game, as well as other worldwide PC outlets. The Immortal Legends mobile game is a beautifully crafted tower defense game, based on the famous Asian “Monkey King” mythology.

“This new relationship with T-Rex of Shanghai, adds a great new partner for high quality games, and opens up access for TapStar to reach the fast-growing Asian market,” Steve Wall, president of Tapstar Interactive, stated in a news release.

Tapstar Interactive also recently launched Boulder Dash 30th Anniversary and Metro 2033: Wars. Wall and Tapster CEO Chris Gray, each with decades of game management experience, have lined up an impressive list of game releases for 2016, including five mobile games and three PC games based on well-known intellectual properties (IP).

iEntertainment Network operates four major online games – including WarBirds, Dawn of Aces, M4 Tank Brigade, and Dogfights. The company plans to continue to grow its WarBirds franchise with a new mobile release, as well as new Bow Hunter 2016 and Crossbow Hunter 2016 mobile games. The company also intends to return to a fully reporting public company later this year.

Founded in 1994, IENT was one of the first online game companies, and its casual games have been featured on EarthLink, Time Warner, and 10 other ISPs as white label casual games. IENT was also one of the first multiplayer online game companies and has been developing and operating online games since 1997, following the launch of its acclaimed WarBirds franchise. J.W. Stealey, CEO of IENT and co-founder of MicroProse Software, has produced more than 500 successful games since 1982, including multi-million unit sellers such as Civilization, F-15 Strike Eagle, Gunship, Pirates!, M1 Tank Platoon, and more.

Learn more by visiting www.corporate-ient.com

Last September’s award of orphan drug status to Nutra Pharma Corporation (OTCQB: NPHC) for RPI-78M for the treatment of Juvenile or Pediatric Multiple Sclerosis was a significant milestone on the company’s road to success as a speculative bio-pharmaceutical company. In an interview (http://dtn.fm/7jXjw) with Stock News Now, CEO Rik Deitsch called the award “the most substantial event in the history of our drug discovery efforts,” but went on to lament that, ironically, the company had been hobbled by its own success.

Although essentially focused on drug discovery, Nutra Pharma markets an over-the-counter (OTC) line of homeopathic remedies. This includes Cobroxin, the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain; Nyloxin and Nyloxin Extra Strength. The latter two are the only non-narcotic and non-addictive treatments for severe (Stage 3) pain. Both Cobroxin and Nyloxin were developed by Nutra Pharma’s wholly-owned drug discovery subsidiary, ReceptoPharm, but these OTC remedies put out by Nutra Pharma have attained more marketing visibility and overshadowed its intellectual property (IP) pipeline. Nevertheless, Cobroxin and Nyloxin are just the tip of the Nutra Pharma iceberg. The company holds 21 patents on treatments for myasthenia gravis (MG), juvenile multiple sclerosis (MS), adrenomyeloneuropathy (AMN), human immunodeficiency virus (HIV) and pain. These, Deitsch explains, are the “blood… the genetics of the company.”

Nutra Pharma’s approach to the treatment of Pediatric Multiple Sclerosis (PMS), so called because it refers to sufferers under the age of 16, is a novel one. At present, PMS is treated with immunosuppressive drugs that can only slow the progression of the disease. Based on clinical studies of RPI-78M, Nutra Pharma expects RPI-78M may have the potential to not only stop further development of the disease but reverse its symptoms. Deitsch has speculated, “If we can get the drug through Phase I and Phase II trials, we plan to license it to a large pharma partner. We expect it to change the way we treat autoimmune diseases.”

Orphan Status for a drug brings many advantages. It gives the sponsoring company tax credits that may amount to as much as 50% of the development costs attributable to qualified clinical testing. This could include remuneration to employees to supervise, carry out and support qualified clinical testing activities. Orphan Status can also mean a reduction or exemption from FDA fees. Under various statutes, beginning with the Prescription Drug User Fee Act of 1992 (PDUFA I), the FDA is authorized to assess user and application fees, but it can grant a waiver or deduction of these fees if ‘A waiver or reduction is necessary to protect the public health OR the assessment of the fee would present a significant barrier to innovation because of limited resources available to the person or other circumstances OR the applicant is a small business submitting its first human drug application… for review.’

That’s not all; Orphan Drug status allows a sponsor exclusive marketing rights for a limited period. Orphan Drug Exclusivity (ODE) is typically for a period of 7 years. After it’s granted, the FDA may not approve applications for generic or second innovator products that contain the same active ingredient and are labeled for the same orphan indication.

Nutra Pharma may be helping sufferers of chronic pain mitigate their discomfort, but it’s a company that aims to do a lot more than that. Earlier this year, it announced it had also applied for Orphan Status for its RPI-78M treatment for MG.

In a recent letter to shareholders, Deitsch said, “It is our goal to complete the Phase I/II trials in pediatric MS over the next 18 months and then either move into Phase III trials or seek a licensing partner. As we have always stated, it is our eventual goal over the next several years to market or license our drugs for the treatment of Multiple Sclerosis and HIV/AIDS. This represents the true potential of Nutra Pharma as a Bio-Pharmaceutical company.”

For more information on the company, visit www.NutraPharma.com

Let us hear your thoughts: Nutra Pharma Corp. Message Board